c-Met antibodies

Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by c-Met.

Saved in:
Bibliographic Details
Main Authors Davies, Julian, Liu, Ling, Lu, Jirong, Vaillancourt, Peter Edward, Wortinger, Mark Andrew, Zeng, Wei
Format Patent
LanguageEnglish
Published 10.07.2012
Online AccessGet full text

Cover

More Information
Summary:Provided are monoclonal antibodies, antigen-binding fragments thereof, and combinations of the foregoing, that bind to, and inhibit the activity of, c-Met, and that are effective in treating cancers and other diseases, disorders, or conditions where pathogenesis is mediated by c-Met.